SENATE 1367117th CongressRead twice and referred to the Committee on Banking, Housing, and Urban Affairs.
United States Pharmaceutical Supply Chain Review Act
- Last Action
- 4/26/2021
CRS Summary
As of 2021-04-26 (00)
United States Pharmaceutical Supply Chain Review Act
This bill requires the Federal Trade Commission to submit annually to Congress a report on foreign investment in the U.S. pharmaceutical industry. The report shall address, among other topics, the effect of the industry's reliance on foreign manufacturing.
Subjects
- Congressional oversight
- Genetics
- Government information and archives
- Government studies and investigations
- Health technology, devices, supplies
- Industrial policy and productivity
- Manufacturing
- Prescription drugs
- Retail and wholesale trades
- U.S. and foreign investments
Sourced from Congress.gov (public domain).
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.